PPARA and brain injury: It seems reasonable tosuggest that a combination of neuroprotective cannabinoids, such asdexanabinol, with other potent anti-inflammatory therapeutic agents, such assynthetic PPAR ligands, may represent a promising new therapeutic avenue forimproving the outcome of traumatic brain injury.